The Latest Breaking News from FDA

US president says electing senators who would help codify Roe v Wade is the ‘fastest route’ to solidifying federal abortion rights – follow the latest

Something is wrong at the Food & Drug Administration's Center for Tobacco Products, and federal courts are beginning to notice.

Diversified healthcare company Abbott (ABT) has demonstrated significant innovations across its segments, and given its dominant market position, the company’s prospects look bright. The stock could be a solid choice as it is well-positioned to survive short-term market fluctuations. Let’s discuss this in detail….

These ‘nutritional supplement diffusers’ claim to fight ADHD or treat anxiety or depression, but experts remain wary of effects

LOS ANGELES — Mark had been wanting to quit using meth for a while when someone pointed him to the folding table propped up at the skid row site where homeless people stop for showers and laundry.

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.

It’s not yet two weeks since the Supreme Court overturned Roe v. Wade, and already the ruling is impeding people’s access to drugs — including drugs not being used for abortions.

The agency is now taking small steps to allow foreign formula manufacturers to import their goods into the U.S.

Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.

U.S. stocks traded higher this morning, following the release of data on initial jobless claims.

Here's a roundup of top developments in the biotech space over the last 24 hours: